-
CF Foundation Awards Armata Up to $5M to Advance AP-PA02 to Trial
The Cystic Fibrosis Foundation has awarded up to $5 million to Armata Pharmaceuticals to advance the development AP-PA02 to a Phase 1b/2 clinical trial. Read more about it here.
What are your thoughts about this news?
Sorry, there were no replies found.
Log in to reply.